Document is current

Any future updates will be listed below

414 A randomized phase II study of systemic therapy plus WeiLeShu (WLS) versus systemic therapy alone in patients with metastatic colorectal cancer (mCRC)

Crossref DOI link: https://doi.org/10.1136/jitc-2021-SITC2021.414

Published Online: 2021-11-10

Published Print: 2021-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark